Takeda Pharmaceutical Company, Limited
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$11.0M
Doctors Paid
65
Transactions
265
2021 Total
$386,845
Payment Breakdown by Category
Research$10.2M (92.9%)
Travel$335,873 (3.1%)
Consulting$165,571 (1.5%)
Food & Beverage$3,788 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10.2M | 29 | 92.9% |
| Travel and Lodging | $335,873 | 107 | 3.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $279,437 | 44 | 2.5% |
| Consulting Fee | $165,571 | 39 | 1.5% |
| Food and Beverage | $3,788 | 45 | 0.0% |
| Education | $930.00 | 1 | 0.0% |
Payments by Type
Research
$10.2M
29 transactions
General
$785,599
236 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Pre-clinical Research | $2.3M | 1 | 2 |
| Preclinical Research | $2.2M | 0 | 1 |
| AMED CiCLE Grant | $1.2M | 0 | 1 |
| Optopatch measurements of neuronal excitability and circuit function in human stem cell-derived neurons | $500,000 | 1 | 3 |
| AMED CiCLE program | $432,163 | 0 | 1 |
| Development of an Integrated Program Centered Around Developing Therapeutic Strategies Relevant to Tauopathies | $293,273 | 0 | 1 |
| TBK1 as a therapeutic target for primary biliary cirrhosis | $171,600 | 0 | 1 |
| Using a PDE2A inhibitor to reverse social phenotypes caused by immune activation during early post-natal development in a mouse model of Tuberous Sclerosis | $154,000 | 0 | 1 |
| Leveraging plasticity mechanisms to accelerate recovery from stroke | $150,000 | 0 | 1 |
| Takeda ODC Translational screening in CDKL5 KO mice | $66,597 | 0 | 1 |
| Evaluating the acute, dose-dependent antiseizure potential of TAK-935 in the Theiler's murine encephalomyelitis virus model of acquired seizures | $55,426 | 0 | 2 |
| Interrogating TBK1 as a therapeutic target for primary biliary cirrhosis | $1,600 | 0 | 1 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Internal Medicine | $2.8M | 12 | $236,584 |
| Hematology & Oncology | $179,171 | 8 | $22,396 |
| Gastroenterology | $131,452 | 8 | $16,432 |
| Urology | $66,680 | 5 | $13,336 |
| Neurology | $48,490 | 2 | $24,245 |
| Diagnostic Radiology | $44,669 | 2 | $22,335 |
| Cardiovascular Disease | $35,023 | 5 | $7,005 |
| Medical Oncology | $26,718 | 5 | $5,344 |
| Clinical Genetics (M.D.) | $22,809 | 1 | $22,809 |
| Endocrinology, Diabetes & Metabolism | $19,751 | 3 | $6,584 |
| Psychiatry | $19,675 | 1 | $19,675 |
| Surgical Oncology | $18,905 | 2 | $9,453 |
| Geriatric Medicine | $15,111 | 1 | $15,111 |
| Neurological Surgery | $14,289 | 1 | $14,289 |
| Surgery | $6,620 | 2 | $3,310 |
| Gynecologic Oncology | $6,617 | 1 | $6,617 |
| Hematology | $6,089 | 2 | $3,045 |
| Pediatric Gastroenterology | $5,350 | 1 | $5,350 |
| Pediatric Hematology-Oncology | $3,000 | 1 | $3,000 |
| Hospice and Palliative Medicine | $930.00 | 1 | $930.00 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2019 |
|---|---|---|---|---|
| Michael Mendelsohn, M.d, M.D | Internal Medicine | Boston, MA | $2.3M | $0 |
| David Margulies, M.d, M.D | Internal Medicine | Waltham, MA | $500,000 | $0 |
| Paul Richardson, Md, MD | Hematology & Oncology | Boston, MA | $70,215 | $0 |
| Stephen Hanauer, Md, MD | Gastroenterology | Chicago, IL | $65,920 | $0 |
| Shaji Kumar, M.d, M.D | Hematology & Oncology | Rochester, MN | $45,516 | $0 |
| Dr. Cory Siegel, M.d, M.D | Diagnostic Radiology | West Roxbury, MA | $42,349 | $0 |
| Dr. Scott Zamvil, Md, MD | Neurology | San Francisco, CA | $30,585 | $0 |
| Axel Grothey, M.d, M.D | Hematology & Oncology | Germantown, TN | $27,995 | $0 |
| Dr. Robert Chen, Md, MD | Internal Medicine | Saint John, IN | $25,242 | $0 |
| Gregory Grabowski, M.d, M.D | Clinical Genetics (M.D.) | Cincinnati, OH | $22,809 | $0 |
| Dr. Leonard Baidoo, Md, MD | Gastroenterology | Memphis, TN | $20,478 | $0 |
| Gregory Mattingly, M.d, M.D | Psychiatry | Saint Charles, MO | $19,675 | $0 |
| Dr. Atsushi Sakuraba, Md, MD | Gastroenterology | Chicago, IL | $18,071 | $0 |
| Corey Siegel, M.d, M.D | Gastroenterology | Lebanon, NH | $17,972 | $0 |
| David Hafler, Md, MD | Neurology | New Haven, CT | $17,906 | $0 |
| Martin Maron, Md, MD | Cardiovascular Disease | Burlington, MA | $17,471 | $0 |
| Andres Forero-Torres, Md, MD | Hematology & Oncology | Birmingham, AL | $16,606 | $0 |
| Ranjana Advani, Md, MD | Medical Oncology | Stanford, CA | $16,206 | $0 |
| William Catalona, Md, MD | Urology | Chicago, IL | $15,545 | $0 |
| James Kirkland, M.d, M.D | Geriatric Medicine | Los Angeles, CA | $15,111 | $0 |
| Isaac Kim, Md, Phd, MD, PHD | Surgical Oncology | New Haven, CT | $14,497 | $0 |
| Dr. Howard Weiner, M.d, M.D | Neurological Surgery | Houston, TX | $14,289 | $0 |
| Gerald Shulman, Md, MD | Endocrinology, Diabetes & Metabolism | New Haven, CT | $14,190 | $0 |
| Marwan Fakih, Md, MD | Internal Medicine | Duarte, CA | $13,800 | $0 |
| John Davis, M.d, M.D | Urology | Houston, TX | $13,088 | $0 |
About Takeda Pharmaceutical Company, Limited
Takeda Pharmaceutical Company, Limited has made $11.0M in payments to 65 healthcare providers, recorded across 265 transactions in the CMS Open Payments database. In 2021, the company paid $386,845. The top product by payment volume is Entyvio ($167,810).
Payments were distributed across 20 medical specialties. The top specialty by payment amount is Internal Medicine ($2.8M to 12 doctors).
Payment categories include: Food & Beverage ($3,788), Consulting ($165,571), Research ($10.2M), Travel & Lodging ($335,873).
Takeda Pharmaceutical Company, Limited is associated with 1 products in the CMS Open Payments database.